The Cigna Group logo

The Cigna Group (CI)

Market Closed
2 Mar, 20:00
NYSE NYSE
$
290. 85
+1.03
+0.36%
$
75.06B Market Cap
16.39 P/E Ratio
6.04% Div Yield
938,877 Volume
24.83 Eps
$ 289.82
Previous Close
Day Range
287.4 292.32
Year Range
239.51 350
Want to track CI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CI earnings report is expected in 58 days (30 Apr 2026)
Here's Why Cigna (CI) is a Strong Momentum Stock

Here's Why Cigna (CI) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 2 weeks ago
Why Cigna (CI) is a Top Growth Stock for the Long-Term

Why Cigna (CI) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 2 weeks ago
Cigna (CI) is a Top-Ranked Value Stock: Should You Buy?

Cigna (CI) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 2 weeks ago
The Cigna Group (CI) Q4 2025 Earnings Call Transcript

The Cigna Group (CI) Q4 2025 Earnings Call Transcript

The Cigna Group (CI) Q4 2025 Earnings Call Transcript

Seekingalpha | 3 weeks ago
Cigna Q4 Earnings Beat Estimates on Higher Specialty Volumes

Cigna Q4 Earnings Beat Estimates on Higher Specialty Volumes

CI's Q4 adjusted EPS beats estimates as Evernorth growth and higher specialty volumes offset fewer medical customers and elevated costs.

Zacks | 3 weeks ago
Make Your Portfolio Healthy Again: The Cigna Group

Make Your Portfolio Healthy Again: The Cigna Group

The Cigna Group stands out as a deeply undervalued healthcare pick, trading at a forward P/E of 9 versus a 10-year average of 13.5. CI targets 10–14% annual adjusted EPS growth long-term, driven by customer growth, pricing, acquisitions, and share repurchases. The stock offers a 2.2% dividend yield with a low payout ratio, supporting continued double-digit dividend growth and a Chowder number near 13.

Seekingalpha | 3 weeks ago
Cigna (CI) Reports Q4 Earnings: What Key Metrics Have to Say

Cigna (CI) Reports Q4 Earnings: What Key Metrics Have to Say

The headline numbers for Cigna (CI) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 3 weeks ago
Cigna (CI) Q4 Earnings and Revenues Beat Estimates

Cigna (CI) Q4 Earnings and Revenues Beat Estimates

Cigna (CI) came out with quarterly earnings of $8.08 per share, beating the Zacks Consensus Estimate of $7.87 per share. This compares to earnings of $6.64 per share a year ago.

Zacks | 3 weeks ago
Cigna Revenue Lifted by Growth in its Evernorth Unit

Cigna Revenue Lifted by Growth in its Evernorth Unit

Cigna Group logged higher revenue in its latest quarter as its pharmacy-benefit business Evernorth continues to grow.

Wsj | 3 weeks ago
Cigna 2025 Profits Hit Nearly $6 Billion Even As Costs Keep Rising

Cigna 2025 Profits Hit Nearly $6 Billion Even As Costs Keep Rising

The Cigna Group Thursday reported 2025 net income of nearly $6 billion despite grappling with rising costs of patients in the health insurance plans it sells and administers.

Forbes | 3 weeks ago
Will Declining Medical Customers Affect Cigna's Q4 Earnings?

Will Declining Medical Customers Affect Cigna's Q4 Earnings?

CI heads into Q4 earnings with rising Evernorth revenues but falling premiums and medical customers, raising questions about the quarter's overall growth outlook.

Zacks | 4 weeks ago
What Analyst Projections for Key Metrics Reveal About Cigna (CI) Q4 Earnings

What Analyst Projections for Key Metrics Reveal About Cigna (CI) Q4 Earnings

Besides Wall Street's top-and-bottom-line estimates for Cigna (CI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.

Zacks | 4 weeks ago
Loading...
Load More